Selected Publications
Margenthaler JA, Klimberg VS. Margin status following partial mastectomy: one size does not fit all! Oncology (Williston Park). 2011 Sep;25(10):899, 903.
Fisher CS, Klimberg VS, Khan S, Gao F, Margenthaler JA. Margin index is not a reliable tool for predicting residual disease after breast-conserving surgery for DCIS. Ann Surg Oncol. 2011 Oct;18(11):3155-9.
Fisher CS, Mushawah FA, Cyr AE, Gao F, Margenthaler JA. Ultrasound-guided lumpectomy for palpable breast cancers. Ann Surg Oncol. 2011 Oct;18(11):3198-203.
Fisher CS, Margenthaler JA. A look into the ductoscope: its role in pathologic nipple discharge. Ann Surg Oncol. 2011 Oct;18(11):3187-91.
Cyr AE, Margenthaler JA, Conway J, Rastelli AL, Davila RM, Gao F, Dietz JR. Correlation of ductal lavage cytology with ductoscopy-directed duct excision histology in women at high risk for developing breast cancer: a prospective, single-institution trial. Ann Surg Oncol. 2011 Oct;18(11):3192-7.
Fisher CS, Ma CX, Gillanders WE, Aft RL, Eberlein TJ, Gao F, Margenthaler JA. Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Response. Ann Surg Oncol. 2011 Jul 2.
Fisher CS, Wachtel MS, Margenthaler JA. Outcomes for Patients who Develop Both Breast and Colorectal Cancer. Ann Surg Oncol. 2011 Jun 24. [Epub ahead of print]
Al Mushawah F, Rastelli A, Pluard T, Margenthaler JA. Metastatic Invasive Breast Cancer Recurrence Following Curative-Intent Therapy for Ductal Carcinoma In Situ. J Surg Res. 2011 May 23. [Epub ahead of print]
Ellis MJ, Suman VJ, Hoog J, Lin L, Snider J, Prat A, Parker JS, Luo J, DeSchryver K, Allred DC, Esserman LJ, Unzeitig GW, Margenthaler J, Babiera GV, Marcom PK, Guenther JM, Watson MA, Leitch M, Hunt K, Olson JA. Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031. J Clin Oncol. 2011 Jun 10;29(17):2342-9. Epub 2011 May 9.
Wilkinson J, Appleton CM, Margenthaler JA. Utility of breast MRI for evaluation of residual disease following excisional biopsy. J Surg Res. 2011 Oct;170(2):233-9. Epub 2011 Apr 13.
Gnerlich JL, Deshpande AD, Jeffe DB, Seelam S, Kimbuende E, Margenthaler JA. Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migration. Ann Surg Oncol. 2011 Jul;18(7):1837-44.
Margenthaler JA. The Cancer Genome: Translating Sequences into Patient Therapeutics. J Surg Res. 2011 Mar 1.
Margenthaler JA. Optimizing conservative breast surgery. J Surg Oncol. 2011 Mar 15;103(4):306-12.
Cyr A, Gillanders WE, Aft RL, Eberlein TJ, Margenthaler JA. Breast cancer in elderly women (= 80 years): variation in standard of care? J Surg Oncol. 2011 Mar 1;103(3):201-6.
Margenthaler JA. Invasive Lobular Breast Cancer: Does Grade Matter? J Surg Res. 2010 Sep 8. [Epub ahead of print]
Pub Med for
Julie A. Margenthaler, M.D.Chapters
Margenthaler J and Klingensmith ME. Stomach. In: Klingensmith ME (ed.).
Washington University Manual of Surgery. 4th Edition. Philadelphia: Lippincott Williams & Wilkins; 2005.
Margenthaler J, Schuerer D, Whinney R. Acute cholecystitis. In:
Clinical Evidence. 11th edition. BMJ Publishing Group; 2004:524-532.
Margenthaler J, Hermann VM, Hickey MS. Surgical Metabolism and Nutrition. In: Way LW, Doherty GM (eds.).
Current Surgical Diagnosis & Treatment. 11th edition. Chapter 11, pp. 156-190.
Margenthaler J, Hermann VM. Nutrition. In: Doherty GM (ed.).
Washington University Manual of Surgery. 3rd Edition. Philadelphia: Lippincott Williams & Wilkins; 2002. Chapter 2, pp. 9-26.